| abstract |
(57) [Summary] [Object] It is an object of the present invention to provide a preventive and / or therapeutic agent for ischemic eye disease containing at least one or more of docosahexaenoic acid or a derivative thereof as an active ingredient. [Effect] By administering the above preventive and / or therapeutic agent, central retinal artery occlusion, retinal artery branch occlusion, Effectively prevents and / or treats ischemic eye diseases such as central retinal vein occlusion, branch retinal vein occlusion, peripheral retinal vascular occlusion, choroidal vascular occlusion, diabetic retinopathy, and anterior ischemic optic neuropathy Can be done. |